Abstract
Objective To study the effect of anti-infective reconstituted bone xenograft (ARBX) as one-stage grafting on treating various chronic osteomyelitis in children. Methods ARBX was used to treat 16 cases of various chronic osteomyelitis in children as one-stage grafting after debridement since September of 2001. There were 8 cases with haematogenous, 3 with primary and 5 with traumatic chronic osteomyelitis. All patients were followed up for an average period of 39 months (range, 12 to 79 months). Results Except 1 case got recurrent infection and another 1 with nonunion due to large segmental bone defect after operation, other 14 cases were cured with the cure rate was 87. 5% (14/16), which is higher than that of classical therapy. Conclusions ARBX has high osteoinductive activity and enhanced anti-infective capability, which enables it to be used as one-stage grafting to treat various chronic osteomyelitis in children. Key words: Osteomyelitis; Bone transplantation; Bone morphogenetic proteins; Anti-bacterial agents
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
